B-Zell-Immuntherapie
EP4775668
15. Juli 2026
Anmelder: The General Hospital Corporation, Holy Cross Hospital, Inc. 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4775668
- Anmeldetag
- 23. Januar 2020
- Veröffentlichung
- 15. Juli 2026
- Rechtsraum
- EP
- IPC
- C12N5/0781
Abstract
The invention, in general, features a method of treating a neurodegenerative disease (such as amyotrophic lateral sclerosis) or a traumatic brain injury in a subject (e.g., a human) in need thereof, the method comprising administering to the subject a therapeutically effective amount of isolated B cells (such as autologous or allogeneic or xenogeneic B cells).
Anmelder
- Firmen
- The General Hospital Corporation
Holy Cross Hospital, Inc. - Land
- 🇺🇸 USA
🇺🇸
The General Hospital Corporation
Rechtsträger des Massachusetts General Hospital, eines Harvard-affiliierten Lehrkrankenhauses in Boston (USA), mit umfangreicher medizinischer Forschung.
1.896 Patente in unserer Datenbank